Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1

Journal of Pediatrics

Volumn 137, Issue 5, 2000, Pages 681-686

  Bjugstad, K B ^a   Goodman, S I ^a   Freed, C R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTARIC ACID;

ACIDEMIA; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; CEREBROSPINAL FLUID; CHILD; DISEASE COURSE; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MOTOR DYSFUNCTION; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; SYMPTOMATOLOGY; WHITE MATTER;

EID: 0033730391     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.108954     Document Type: Article

References (58)

1. Glutaric aciduria: Inherited deficiency of glutaryl-CoA dehydrogenase activity
2. Glutaric aciduria: A 'new' disorder of amino acid metabolism
3. Organic acidemias due to defects in lysine oxidation: 2-ketoadipic acidemia and glutaric acidemia
4. A fibroblast glutaryl-CoA dehydrogenase assay using detritiation of 3H-labelled glutaryl-CoA: Application in the genotyping of glutaryl-CoA dehydrogenase locus
5. Hypothesis: A role for quinolinic acid in the neuropathology of glutaric aciduria type 1
6. Glutaric acidemia (type 1)
7. Early signs and course of disease of glutaryl-CoA dehydrogenase deficiency
8. 18FDG) PET scan of the brain in glutaric aciduria type 1: Clinical and MRI correlations
9. Dystonia and dyskinesia in glutaric aciduria type 1: Clinical heterogeneity and therapeutic considerations
10. Intermittently progressive dyskinetic syndrome in glutaric aciduria
11. Glutaric aciduria type 1 mlsdiagnosed as Leigh's encephalopathy and cerebral palsy
12. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency
13. Glutaric aciduria type 1 (glutaryl-coA-dehydrogenase deficiency): Advances and unanswered questions. Report from an international meeting
14. Glutaric aciduria type 1: Clinical heterogeneity and neuroradiologic features
15. Acute profound dystonia in infants with glutaric acidemia
16. Neuropathology in glutaric acidaemia type 1
17. Macrocephaly: An important indication for organic acid analysis
18. Two cases of glutaric aciduria type 1: Clinical and neuropathological findings
19. Variable clinical and biochemical presentation of seven Spanish cases with glutaryl-CoA-dehydrogenase deficiency
20. Clinically asymptomatic glutaric aciduria type 1 in a 4 5/12-year-old girl with bilateral temporal arachnoid cysts
21. Striatal degeneration and spongy myelinopathy in glutaric acidemia
22. Glutaric acidemia as a cause of striatal necrosis in childhood
23. Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid
24. Nerve cell lesions caused by 3-hydroxyglutaric acid: A possible mechanism for neurodegeneration in glutaric acidaemia 1
25. Glutaric aciduria type 1: Enzymatic and neuroradiologic investigations of two kindreds
26. Phenotypic variability in glutaric aciduria type 1: Report of fourteen cases in five Canadian Indian kindreds
27. Glutaric aciduria type 1: A common cause of episodic encephalopathy and spastic paralysis in the Amish of Lancaster county, Pennsylvania
28. Glutaric aciduria type 1: From clinical biochemical, and molecular diversity to successful therapy
29. Nutrition support for glutaric acidemia type 1
30. Diagnosis and management of glutaric aciduria type 1
31. Prevention of cerebral palsy in glutaric aciduria type 1 by dietary management
32. Treatment of glutarvl-CoA dehydrogenase deficiency (glutaric aciduria)
33. Glutaric aciduria type 1: An atypical presentation together with some observations upon treatment and possible cause of cerebral damage
34. A case of glutaric acidemia type 1: Effect of riboflavin and carnitine
35. L-carnitine treatment in glutaric aciduria type 1
36. Glutaryl co-A dehydrogenase mutations in glutaric acidemia (type 1): Review and report of thirty novel mutations
37. Glutaryl-coenzyme A dehydrogenase deficiency: A distinct encephalopathy
38. Megalencephaly in the neonatal period as the initial manifestation of glutaric aciduria type 1
39. CT-scan findings in an infant with glutaric aciduria type 1
40. Early prenatal diagnosis in two pregnancies at risk for glutaryl-CoA dehydrogenase deficiency
41. Subdural hemorrhage as an initial sign of glutaric aciduria type 1: A diagnostic pitfall
42. Glutaric aciduria type 1: Biochemical investigations and postmortem findings
43. Glutaric aciduria type 1: Unusual biochemical presentation
44. Glutaric aciduria: Improved MR appearance after aggressive therapy
45. Glutaric aciduria type 1 presenting with hypoglycemia
46. Glutaric aciduria: Biochemical and morphologic considerations
47. Ketotic episodes in glutaryl-CoA dehydrogenase deficiency (glutaric aciduria)
48. Glutaric aciduria: Clinical and laboratory findings in two brothers
49. Severe clinical course with recurrent hyperpyrexia in a patient with glutaric acidemia type 1
50. Glutaric aciduria type 1: An underdiagnosed cause ofencephalopathy and dystonia-dyskinesia syndrome in children
51. Glutaric acidemia: A metabolic disorder causing progressive choreoathetosis
52. Glutaryl-CoA dehydrogenase deficiency presenting as 3-hydroxyglutarlc aciduria
53. Chronic subdural hematoma, as an initial manifestation of glutaric aciduria type-1
54. Early clinical manifestation of glutaric aciduria type 1 and nephrotic syndrome during the first months of life
55. Glutaric aciduria type 1 in adulthood
56. Significance cf bound glutarate in the diagnosis of glutaric aciduria type I
57. L-glutaric acidemia: Investigation of a patient and his family
58. Antenatal diagnosis of glutaric acidemia